Law Kok Thye controls 74% of Leform. Will he be crazy to short or sell it down?

We shall see! Stay tuned!

Back to the Future @ 18¢

KUALA LUMPUR (Nov 30 2022): Leform Bhd made a subdued debut on the ACE Market of Bursa Malaysia on Wednesday (Nov 30) with its opening share price of 19.5 sen against its initial public offering (IPO) price of 23 sen. The counter closed 5.1% lower than its IPO price, at 18.5 sen.

Remember the brainchild idea of Ismail Sabri (the turtle eggs eater) regarding the Bumi Low Yat, most had been closed down. A donkey just can't be trained to be a thoroughbred race horse.

Would love to see the breakdown of the unemployed graduates by Race. I bet many of them are selling Ramly Burgers at road sides.

chon99,

Nice to meet you too!
We got vindicated today! I sold 60% to lock in profits. Will buy back below 76 sen.

Tut tut.....

Sold all my trading shares. Kept only core shares.

Tut tut...

Tut tut...

Forward PE of 18
Easily a double in 2023

Tut tut.....

The company has a strong unbilled order book of RM558.34 million (as at Aug 30, 2022), which provides it with earnings visibility until the financial year ending March 31, 2024 (FY2024). It has 35 ongoing EPCC projects for solar PV facilities, with a total contract value of RM685.30 million.

Tut tut.....

Do u think IB, insiders, rich folks will hang out here?

This site is purely for entertainment purposes.

Tut tut.....

tut tut.....

tut tut.....

The adjusted profit after tax (“PAT”) of RM5.8 million for the quarter, in turn, was 80.0%
higher than Q2FY2023’s PAT of RM3.2 million.

tut tut tut.....

tut tut

Taiwan Superconductor International Semiconductor Technology Co Ltd (TSIST)
IS NOT Taiwan Semiconductor Manufacturing Company, Limited (TSMC).

Never heard of TSIST!

Dow adds more than 800 points, or 2.5%, in best day of 2022
Stocks rally in back-to-back day of gains

Dow 30
34,058.75
+834.92 (+2.51%)

Nasdaq
13,694.62
+221.04 (+1.64%)

Crude Oil
91.92
-0.89 (-0.96%)

Dividend 0.0517%
(0.06 sen / 116 sen) x 100 = 0.0517%

Math 101
Dividend set at 0.6 sen per share
1 lot = 100 shares
100 X 0.6 sen = 60 sen dividend per lot

China Reports is an ANTI-CHINA channel set up by The BL based in the US to provide viewers with the biased news about China. They hope to build a bridge to help the outside world gain an dishonest view of China with fake information collected and delivered to readers based on dishonesty, inaccuracy, and subjectivity. China Reports considers upholding these dirty principles as its immoral obligation.

The Tan family is still in full control of ES Ceramics.

R&R are just regular shareholders like us. Let's keep the status quo.

https://www.enanyang.my/%E8%B4%A2%E7%BB%8F%E6%96%B0%E9%97%BB/%E3%80%90%E7%8B%AC%E5%AE%B6%E3%80%91%E5%8D%A1%E9%A9%AC%E9%80%BE20%E8%82%A1%E6%9D%83%E8%BD%AC%E7%BB%99%E5%AE%B6%E4%BA%BA-%E9%99%88%E6%B0%8F%E5%AE%B6%E6%97%8F%E6%B2%A1%E9%80%80%E5%87%BAes%E9%99%B6%E7%93%B7

Today's P/E = 0.505 / 0.0601 = 8.4

Current FY2021:

Q1: 1.50 sen
Q2: 0.87 sen
Q3: 1.82 sen
Q4: 1.82 sen (Forecast but likely much higher)

So, the yearly EPS = 6.01 sen.

Today's P/E = 0.505 / 0.0601 = 8.4

https://www.enanyang.my/%E8%B6%8B%E5%8A%BF/%E3%80%90%E7%8B%AC%E5%AE%B6%E3%80%91%E6%9C%AA%E9%9B%A8%E7%BB%B8%E7%BC%AA-%E5%90%B8%E5%8F%96%E7%BB%8F%E9%AA%8C-mco%E6%88%BF%E9%94%80%E4%B9%9F%E5%8F%AF%E6%BB%A1%E5%A0%82%E7%BA%A2

usedor1 hahaha this new development shows none of you ATian knows how to read. Hello, this is not approval la ok, they're just applying only. Any tom dick and harry can apply.
05/02/2021 11:49 PM

Oldmantc Oskchoon.. Your comment is misleading. FDA certificate is not granted yet.
The one that is being circulated is a document issued by their US agent (FDA Basics LLC).
06/02/2021 12:01 AM

===================================================================
FDA is allowing any glove company to just register and sell medical gloves in the USA due to the shortages caused by Covid-19. AGESB DOES NOT need any FDA approval at this time, but proper labelings are required.

As AGESB is now registered, it can start selling medical gloves to the USA with proper labeling guidelines from FDA.
=================================================================

AT SYSTEMATIZATION BERHAD Announcement details

Type Announcement
Subject OTHERS

Description
AT SYSTEMATIZATION BERHAD ("ATS" OR THE "COMPANY")
REGISTRATION OF AT GLOVE ENGINEERING SDN. BHD. A WHOLLY OWNED SUBSIDIARY OF THE COMPANY WITH THE U.S. FOOD AND DRUG ADMINISTRATION

The Board of Directors of AT Systematization Berhad (“ATS” or the “Company”) is pleased to inform that AT Glove Engineering Sdn. Bhd. (“AGESB”), a wholly owned subsidiary of the Company had on 1 February 2021 received the establishment registration with the Food and Drug Administration of the United States (“FDA”).

The disposable gloves are classified as medical devices and are subject to full FDA certification before it can be sold, to ensure the safety and effectiveness of the gloves.

Pursuant to a guidance issued by the FDA in March 2020, in view of the ongoing COVID-19 pandemic, the FDA DOES NOT object the distribution and use of gloves which has yet to comply with the regulatory requirements for full FDA certification, provided that the gloves are labelled in accordance with the guidelines issued by the FDA.

Following the receipt of establishment registration with FDA, AGESB can now export its medical examination gloves to the United States.

This announcement is dated 5 February 2021.

C. Patient Examination Gloves (FDA Guidelines during the COVID-19 outbreak)

A non-powdered patient examination glove is a disposable device intended for a medical purpose that is worn on the examiner’s hand or finger to prevent contamination between patient and examiner. A non-powdered patient examination glove does not incorporate powder for purposes other than manufacturing. The final finished glove includes only residual powder from manufacturing.

These devices are class I (reserved) and subject to premarket notification requirements under section 510(k) of the FD&C Act because general controls are sufficient to provide reasonable assurance of the safety and effectiveness of the device and the devices are intended for a use which is of substantial importance in preventing impairment of human health or presents a potential unreasonable risk of illness or injury, under sections 513(a)(1)(A) and 510(l)(1) of the FD&C Act. In general, FDA recommends that health care providers follow current Centers for Disease Control and Prevention (CDC) guidance regarding PPE that should be used during the COVID-19 outbreak. Health care employers must also comply with standards of OSHA that require PPE to protect workers and that apply to infectious disease hazards.

FDA recognizes the urgent need during the COVID-19 public health emergency for patient examination gloves due to increased use and demand which has led to shortages in their availability.

To help ensure the availability of these devices during the COVID-19 public health emergency, FDA DOES NOT intend to object to the distribution and use of patient examination gloves that do not comply with the following regulatory requirements, where the gloves do not create an undue risk in light of the public health emergency: prior submission of a premarket notification under section 510(k) of the FD&C Act and 21 CFR 807.81, Registration and Listing requirements in 21 CFR 807, Quality System Regulation requirements in 21 CFR 820, reports of corrections and removals in 21 CFR Part 806, and Unique Device Identification requirements in 21 CFR Part 830 and 21 CFR 801.20. FDA currently believes such devices would not create such an undue risk where:

• The product includes labeling that accurately describes the product as an “unpowdered glove” (as opposed to a surgeon’s or patient examination glove), accurately describes its sterility status when individually packaged (non-sterile), does not claim the product as being free of a specific material (e.g., latex free), and includes a list of the body contacting materials;

• The product includes labeling with general statements and makes recommendations that would reduce sufficiently the risk of use, for example, a general statement about devices that have not been cleared by FDA and recommendations against use: when FDA-cleared gloves are available, in surgical settings or where significant exposure to liquid bodily or other hazardous fluids may be expected, and in clinical settings where the infection risk level is high; and

• The product is not intended for any use that would create an undue risk in light of the public health emergency, for example, the labeling does not include uses with chemotherapy drugs, fentanyl, and other opioids, uses for allergy or dermatitis prevention, uses for antimicrobial or antiviral protection, or uses for infection prevention or reduction.

KSTAR down 9%
KSTAR-WA down 37%, expiring 5 months later on 10-Apr-2021, exercise price @ 8 sen, 8+16=24 sen, a discount of 21%.

Please kindly explain the huge discrepancies!

KSTAR (5172)
0.305 -0.03 (8.96%) V=149,417,900, Ave=46,658,735

KSTAR-WA (5172WA)
0.16 -0.095 (37.25%) V=10,714,100, Ave=7,132,800

Today kstar will rebound 0.45...?

YES YES YES!

Isn't the PE of 128 for its industries is too high?

PE 128 / 4 = PE 32, fair price = 0.31
PE 128 / 5 = PE 26, fair price = 0.24
PE 128 / 6 = PE 21, fair price = 0.20
PE 128 / 7 = PE 18, fair price = 0.17
PE 128 / 8 = PE 16, fair price = 0.15

Prolexus: to buy or to sell?

By Koon Yew Yin
Posted on October 2, 2020

In the last few days many people in my chat group asked for my opinion of Prolexus because its EPS for its latest quarter ending July jumped to 13.67 sen. But it has been losing money in the previous 2 quarters as shown on the table below.

I Google to find out more about the company so that I can give an honest opinion. The company produces a wide range of clothing from outerwear, tops and bottoms, children and adult wear. The company also specializes in producing clothing for Running, Training, Performance Sport, Gym and Yoga.

The company has been losing money because it cannot compete with other cheaper producers from Vietnam, Cambodia and China.

Face mask production

Recently due to Covid 19 pandemic there was a sudden surge in the demand for face masks and the company took advantage of the situation to produce face masks. As a result, the company could turn around from losing money to report profit. Many short-sighted investors are rushing to buy the share to push up the price.

Long term investors should know that it is very easy to make face mask. Moreover, face mask can be washed and reused. Soon there will be less demand for face masks and the company will not be able to make profit.

Everyone is entitled to his opinion. Only time will tell who is right and who is wrong. I am obliged to tell you that I do not have this share and whether you buy or sell will not affect me.

who the fuch is 艾毕斯? Scammer?

rubbish article +1M

Very suspicious names, don't u think so? Both may be ular mak?

@ocs5858
@kc02245

ocs5858 is just being cynical towards the naysayers and hater losers.

Your are welcome, aizaclunk.

Once we have our own WhatsApp ATS Group, we can concentrate to help each other getting educated and more importantly, making lots of $$.

No more haters & losers kacau-ing us daily...

Let us leave this i3 shit hole for the haters and losers.

I will take the challenge to set up the WhatsApp ATS Group Chat group instead.

I will scrutinize each handle's posts, will only admit genuine investors or speculators.

Will post the pic there.

Please email your i3 handle + WhatsApp ph no to:

kc02245@gmail.com

Photos will be shared ONLY with the genuine investors. No haters nor naysayers.

I will review your posts in details to see if I should send you the pictures or not.

Please email your i3 handle + email (prefer WhatsApp ph no, hope to set a group chat) to:

kc02245@gmail.com

AT TRADING VOLUMES

0.080 357,200
0.075 25,598,800
0.070 2,731,600

BID 29,881,000 @0.070
OFFER 2,166,400 @0.075

"JAWATAN KOSONG" big banner at the front gate of the Chemor plant.

The site was bustling with activities. Many forklifts carrying steel beams roaming everywhere. Not a safe place for non construction workers.

Posted by PN17 > Sep 20, 2020 2:36 AM | Report Abuse

大马第一中文新媒体财经网站
THE EDGE揭秘─21家仙股股东董事成员或同批人
19/09/2020
权威财经周刊THE EDGE揭露，大马股市过去几个月仙股交投狂热，其中有21家上市公司的股东，董事，很可能是同一批人，这些股票的股价波动幅度惊人，成交量也十分庞大。

这些公司有很多共同点，大多数是亏损公司，股价都是仙股级别，经常占据交易榜前十名，股价的起伏上下惊人。

根据THE EDGE报导，21家被点名的公司中，有9家公司的总部地址，注册地址都相同，即座落在八打灵再也丽阳镇的联和大厦（WISMA LIEN HOE）。

这9家公司包括宜鼎（AT），富科期（FOCUS），万通科技（MTOUCHE），FINTEC环球（FINTEC），XOX说（XOX），M3科技（M3TECH）和NETX科技（NETX）等。

报导指出，联合大厦原本是上市公司联合（LIENHOE）的物业，不过它在2006年以RM1价格，附加4300万令吉债务，脱售给一家私人有限公司E Globafocus有限公司。

EGlobafocus是由CUBES INNOVATIVE有限公司持有68%股权；CUBES INNOVATIVE由两名股东持有99%股权，这两人是商人蔡福顺和温运伦（人名译音）。

蔡氏和温氏曾在2014年7月遭证券监督委员会控以操控上市公司DVM科技股价罪名。

温氏个人在证券监督委员会有多项指控，包括2009年被控滥用上市公司FTEC资源的249万令吉公司资金，自该事件曝光後，温氏就几乎没有在股市活动。

不过，他的两名姐妹温安妮和温秀妮则各别持有另一家仙股公司喜得狼（XDL）的3.64%和0.67%股权。

上述9家公司中，FINTEC环球是最受注目的公司，这家公司的几批股票由一家私人控股公司SANSTON FINACIAL GROUP LTD持有。

诡异的是，SANSTON在21家上市公司的股东名单中都出现。

最近遭收购的海外天（OVERSEA）也在21家公司名单之中。

THE EDGE报导指出，21家公司市值最高的公司是富科斯（FOCUS），市值高达50亿令吉，尽管其季度净利仅有232万令吉，但股价却高得惊人。

随THE EDGE揭秘报导之後，证券监督委员会和大马交易所会不会采取跟进行动，调查这21家公司，颇受市场注目

https://9shares.my/the-edge%e6%8f%ad%e7%a7%98%e2%94%8021%e5%ae%b6%e4%b...

THIS IS GORENG OLD NEWS FROM 19/09/2020

THE EDGE揭秘─21家仙股股东董事成员或同批人
19/09/2020

That is why I make it a top priority to pay an unofficial visit to the Chemor factory.

I was asked politely by the ATS personnel to leave. The reasons being they don't want any freak accident to happen and then they need to stop work and delay the project. Based on my chat with him, all goes well as planned.

This is a high risk & high return stock.

Only buy with your risks money.

If you are worry about this and that, please sell and buy the major glove shares:

TopGlove, SuperMax, Hartalega, Kossan, CarePlus, Comfort & Rubberex.

I got all 1M shares @ 7.5 sen.

I plan to collect MORE if it goes down further.

Yesterday, I had visited the Chemor plant and took many pictures. I am confident that this is a winner if we can hold for at least 6 months.

It's a waste of time arguing with all these good for nothing cork suchers and mo fuchers.

MasterOfSailang @seongkeat see kc02245 what he wrote. then and now. told you d. a lot of talk cockers. see what he wrote.. All the blowers.
23/09/2020 7:46 PM
====================================================================

There are a few haters who kept spinning that if the PGSB deal fells off, that will be the end of AT. The share price will go to 4 sen or even zero. That is no longer true since RESB & RISB came into picture later.

PGSB is no longer KEY to the success of AGESB.

RESB & RISB play a very important role now for the success of AGESB.

Before barking like a mad dog again, please look at the timeline in details.

Many events had happened “then & now”. We should always reevaluate with the dynamic day-to-day annoncements from ATS.

MY TP OF 30 SEN REMAINS INTACT. THE GOAL REMAINS THE SAME ALBEIT WITH THE RESHUFFLING OF SOME OF THE PLAYERS.

On 26 June 2020 announced the proposed acquisition by the Company’s wholly-owned subsidiary, AGESB of the entire equity interest in Pearl Glove (Malaysia) Sdn Bhd (“PGSB”).

On 10 August 2020 entered into a supply contract with Ripcol Engineering Sdn. Bhd. (Company No. (201501003548 (1128880-M)) (“RESB”) to engage RESB as AGESB’s contractor for the design, fabrication, installation, testing and commissioning a total of 6 production lines (“Works”) (“Letter of Award”). The Works include the setting up of 1 single former dipping line and 5 double former dipping line for the production of medical gloves (“Products”) (“Proposed Medical Glove Lines”).

On 27 August 2020 entered into a Sale and Purchase Agreement (“Agreement”) with Ripcol Industries Sdn. Bhd. [Registration No. 200201019333 (586996-K)] (“RISB” or the “Vendor”) for purchase of two (2) adjoining parcels of leasehold industrial lands, together with industrial premises as further defined in Section 4 of this announcement (“Property”), for a total purchase consideration of Ringgit Malaysia Ten Million and Three Hundred Thousand (RM10,300,000.00).

On 15 September 2020, the Company is pleased announce that its wholly owned subsidiary, AT Glove Engineering Sdn. Bhd. had entered into a facility set up agreement with Ripcol Engineering Sdn. Bhd.

On 23 September 2020. The terms of the facility set up agreement are based on the terms set out in the Letter of Award, except for the amount of the total contract price which has been reduced to Ringgit Malaysia Thirty Five Million Nine Hundred Seventeen Thousand and One Hundred (RM35,917,000.00) only to exclude the certification of products which will be handled by a separate consultant.

UMNO57 @kc02245, saya merujuk balik petikan ko yg bertarikh 28-June 09:59pm.

Kerana ko tulis seperti di bawah pd tarikh tersebut, maka saya dgn para2 pembeli saham yg lain telah melabur di kaunter AT.

Kini ko cakap lain pulak ??

===================

Dulu 28-June
ATS belum disclose Ripcol Industries Sdn. Bhd. (“RISB”) JV deal.

Kini 23-Sep,
Dengan JV with RISB, ATS’s GLOVE business is still worth at least 30 cents.

ATS's acquisition of PGSB x penting lagi.

PEARL GLOVE (MALAYSIA) SDN BHD (“PGSB”)
FYE 2018
Revenue: 14,986,000
Profit before tax: 255,000
Profit after tax: 253,000
Profit Margin: 1.69%

*Is PGSB worth 22M? A big NO.
*Acquring PGSB is a NON issue now.
*Acquring or JV with Ripcol Industries Sdn. Bhd. (“RISB”) is the best option for AT Glove Engineering Sdn Bhd (“AGESB”).

Both of them are fuching retards! Why waste precious time on them?

It is the big boy syndicates that are controlling the AT share price. It is naive for the naysayers to think that they can bring down the share price with fake, negative & hateful comments.

0.095 <== definitely up +0.005 +5.26%

AT 9 / 0 / 0.0% (Yawn, go back to nap)

0.095 Vol=182,000 (0.54%)
0.090 Vol=30,820,400 (91.54%)
0.085 Vol=2,668,200 (7.92%) <=== panic selling